Contact
    Start Publications Temperature-Controlled Reversible Exposure and Hiding of ...
    ←  Publication Finder
    QSense

    Temperature-Controlled Reversible Exposure and Hiding of Antimicrobial Peptides on an Implant for Killing Bacteria at Room Temperature and Improving Biocompatibility in Vivo

    Year: 2018

    Journal: ACS Appl. Mater. Interfaces, Volume 10, OCT 24, page 35830–35837

    Authors: Zhan, Jiezhao; Wang, Lin; Zhu, Yuchen; Gao, Huichang; Chen, Yunhua; Chen, Junjian; Jia, Yongguang; He, Jingcai; Fang, Zhou; Zhu, Ye; Mao, Chuanbin; Ren, Li; Wang, Yingjun

    Keywords: antimicrobial peptides; temperature responsive; click chemistry; biocompatibility; implants

    Modification of implants by antimicrobial peptides (AMPS) can improve the antimicrobial activity of the implants. However, AMPs have some cytotoxicity in vivo when they are exposed at body temperature. To tackle this challenge, we propose to develop a new approach to generating a smart antimicrobial surface through exposure of AMPS on the surface. A polydopamine film was first formed on the substrates, followed by the conjugation of a temperature-sensitive polymer, poly(N-isopropylacrylamide) (pNIPAM), to the film through atom transfer radical polymerization (ATRP). Then, AMPs were conjugated to the NIPAM on the resultant pNIPAM-modified surface through a click chemistry reaction. Because of the temperature-sensitive property of pNIPAM, the AMPS motif was more exposed to the external environment at room temperature (25 degrees C) than at body temperature (37 degrees C), making the surface present a higher antimicrobial activity at room temperature than at body temperature. More importantly, such a smart behavior is accompanied with the increased biocompatibility of the surface at body temperature when compared to the substrates unmodified or modified by AMPs or pNIPAM alone. Our in vivo study further verified that pNIPAM-AMP dual modified bone implants showed increased biocompatibility even when they were challenged with the bacteria at room temperature before implantation. These results indicate that the implants are antibacterial at room temperature and can be safely employed during surgery, resulting in no infection after implantations. Our work represents a new promising strategy to fully explore the antimicrobial property of AMPs, while improving their biocompatibility in vivo. The higher exposure of AMPs at room temperature (the temperature for storing the implants before surgery) will help decrease the risk of bacterial infection, and the lower exposure of AMPs at body temperature (the temperature after the implants are placed into the body by surgery) will improve the biocompatibility of AMPs.
    View publication